Bristol-Myers Squibb’s Opdivo Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo ...